Sangamo Therapeutics: Communiqué Normé Related to the Offeror’s Draft Prospectus Related to the Simplified Public Tender Offer Targeting the Shares of the Company
Sangamo Therapeutics, Inc. (SGMO)
Last sangamo therapeutics, inc. earnings: 2/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.sangamo.com
Company Research
Source: Business Wire
This communiqué normé remain subject to examination by the French financial markets authority (Autorité des Marchés Financiers – AMF) RICHMOND, Calif.--(BUSINESS WIRE)-- Regulatory News: Sangamo Therapeutics Inc. (NASDAQ:SGMO): This Communiqué Normé (the “Communiqué Normé”) was prepared and filed with the AMF on 2 October 2018, in accordance with articles 231-13, 231-16 and 231-18 of the AMF’s General Regulations. The offer, the Offeror’s Draft Prospectus and the target prospectus remain subject to examination by the AMF. This Offeror’s Draft prospectus is available on the AMF’s website (www.amf-france.org) and on Sangamo Therapeutics Inc.'s (www.sangamo.com)
Show less
Read more
Impact Snapshot
Event Time:
SGMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SGMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SGMO alerts
High impacting Sangamo Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SGMO
News
- Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) [Yahoo! Finance]Yahoo! Finance
- Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)Business Wire
- What You Need To Know About The Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Analyst Downgrade Today [Yahoo! Finance]Yahoo! Finance
- Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering [Yahoo! Finance]Yahoo! Finance
- Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct OfferingBusiness Wire
SGMO
Earnings
- 3/13/24 - Miss
SGMO
Sec Filings
- 4/19/24 - Form ARS
- 4/19/24 - Form DEF
- 4/5/24 - Form SC
- SGMO's page on the SEC website